Angelika Amon

From WikiMD's Food, Medicine & Wellness Encyclopedia

Angelikaamon

Angelika Amon

Angelika Amon was an Austrian-American molecular biologist known for her groundbreaking research in the field of cell biology. She was born on October 20, 1967, in Vienna, Austria. Amon received her Ph.D. in molecular biology from the University of Vienna in 1994. She later moved to the United States to pursue her postdoctoral studies at the Massachusetts Institute of Technology (MIT).

Throughout her career, Amon made significant contributions to the understanding of cell cycle regulation and aneuploidy. Her research focused on the molecular mechanisms that control cell division and how errors in these processes can lead to genetic instability and cancer. Amon's work has been instrumental in advancing our knowledge of the fundamental processes that govern cell growth and proliferation.

In addition to her research accomplishments, Amon was a dedicated mentor and educator. She trained numerous students and postdoctoral fellows who have gone on to make their own contributions to the field of molecular biology. Amon was also a passionate advocate for increasing diversity and inclusion in the scientific community.

Amon's work has been widely recognized and she received numerous awards and honors throughout her career. She was elected to the National Academy of Sciences in 2018 and was a Howard Hughes Medical Institute Investigator. Amon's research has been published in top scientific journals and has had a lasting impact on the field of cell biology.

Tragically, Angelika Amon passed away on October 29, 2020, leaving behind a legacy of scientific excellence and mentorship. Her contributions to the field of molecular biology continue to inspire future generations of scientists to push the boundaries of knowledge and discovery.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD